The glutamate transport inhibitor DL-Threo-?-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells
1 Department of Biology, Faculty of Science, University of Copenhagen, 13, Universitetsparken, Copenhagen, DK-2100, Denmark
2 Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, 13, Universitetsparken, Copenhagen, DK-2100, Denmark
3 Faculty of Health and Medical Sciences, Institute of Veterinary Disease Biology, University of Copenhagen, Copenhagen, Denmark